Search Tag: Harbour BioMed
2023 08 Aug
Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology announced the appointment of Dr. Albert R. Collinson as independent non-executive director. Dr. Collinson has over 30 years of experience in the pharmaceutical and biotechnology...Read more
2022 14 Apr
Harbour BioMed has announced the appointment of Dr. Humphrey Gardner as Chief Medical Officer (CMO). Dr. Gardner will be responsible for leading the global product development of the Company, including pipeline strategy, clinical development plan and operations, and product registration. Dr. Gardner has more than 30 years industry experience, achievement...Read more